Aquestive Therapeutics (AQST) Financials: Revenue & Earnings
AQST$4.16+0.09 +2.09%
$521.50M
Market Cap
—
P/E
—
Forward P/E
—
Score
Aquestive Therapeutics (AQST) Financials: Revenue & Earnings
AQST price $4.16 +0.09 +2.09%
- Ticker
- AQST
- Price
- $4.16
- Change
- +0.09 +2.09%
- Market cap ?
- $521.50M
- Beta ?
- 1.49
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
Fair value
AQST fair value $10.75. Price $4.16. Price is 61% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 8.67M. Growth 14.59%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.5). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 125.51M. Net debt 10.28M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | -0.10 | — | 11.02M |
| 2026-08-11 | -0.18 | -0.10 | 13.82M | 11.42M |
| 2026-05-13 | -0.07 | -0.14 | 14.45M | 10.90M |
| 2026-03-04 | -0.26 | -0.13 | 13.02M | 13.29M |
| 2025-11-05 | -0.14 | -0.11 | 12.81M | 12.94M |
| 2025-08-11 | -0.14 | -0.18 | 10.00M | 12.20M |
| 2025-05-12 | -0.24 | -0.17 | 8.72M | 12.23M |
| 2025-03-05 | -0.19 | -0.14 | 11.87M | 13.11M |
| 2024-11-04 | -0.13 | -0.12 | 13.54M | 13.13M |
| 2024-08-06 | -0.03 | -0.11 | 20.10M | 12.38M |
| 2024-05-07 | -0.17 | -0.09 | 12.05M | 12.26M |
| 2024-03-05 | -0.12 | -0.08 | 13.21M | 11.63M |
| 2023-11-06 | -0.03 | -0.11 | 13.00M | 11.63M |
| 2023-08-07 | -0.10 | -0.11 | 13.24M | 11.01M |
| 2023-05-02 | 0.11 | -0.10 | 11.13M | 9.92M |
| 2023-03-07 | -0.23 | -0.21 | 10.68M | 10.42M |
| 2022-11-01 | -0.23 | -0.30 | 11.46M | 11.00M |
| 2022-08-02 | -0.36 | -0.41 | 13.27M | 10.57M |
| 2022-05-03 | -0.32 | -0.45 | 12.27M | 10.13M |
| 2022-03-08 | -0.38 | -0.47 | 11.08M | 9.36M |
| 2021-11-02 | -0.37 | -0.40 | 13.29M | 11.01M |
| 2021-08-03 | -0.33 | -0.42 | 15.35M | 15.35M |
| 2021-05-04 | -0.41 | -0.44 | 11.12M | 6.24M |
| 2021-03-09 | -0.60 | -0.46 | 7.15M | — |
| 2020-11-04 | -0.49 | -0.50 | 8.26M | 7.75M |
| 2020-08-04 | -0.07 | -0.43 | 21.68M | 133.15M |
| 2020-05-05 | -0.49 | -0.52 | 8.77M | 8.41M |
| 2020-03-11 | -0.48 | -0.45 | 16.42M | 13.34M |
| 2019-11-05 | -0.54 | -0.78 | 12.42M | 11.58M |
| 2019-08-06 | -0.82 | -0.67 | 11.13M | 8.41M |
| 2019-05-08 | -0.59 | -0.49 | 12.64M | 10.71M |
| 2019-03-14 | -0.56 | -0.91 | 16.82M | 15.32M |
| 2018-11-06 | -0.49 | -0.49 | 13.27M | 8.91M |
| 2018-09-04 | -1.90 | -0.24 | 13.93M | — |
| 2018-07-26 | 0.20 | — | 23.41M | — |
| 2017-12-31 | -0.50 | — | 12.20M | — |
| 2017-09-30 | 0.42 | — | 27.15M | — |
| 2017-06-30 | -0.29 | — | 11.14M | — |
| 2017-03-31 | -0.07 | — | 16.44M | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-21 | Cochran John | Buy | 62.23K | — | — |
| 2026-10-15 | Barber Daniel | Sell | 25.00K | $4.22 | 105.60K |
| 2026-10-15 | Daly Richard J | Other | 0 | — | — |
| 2026-09-15 | Barber Daniel | Sell | 25.00K | $4.82 | 120.49K |
| 2026-09-09 | Korczynski Sherry | Buy | 8.75K | $2.65 | 23.19K |
| 2026-09-09 | Korczynski Sherry | Sell | 8.75K | $5.22 | 45.67K |
| 2026-09-09 | Korczynski Sherry | Sell | 8.75K | $2.65 | 23.19K |
| 2026-09-09 | Boyd Peter E. | Buy | 2.29K | $0.96 | 2.20K |
| 2026-09-09 | Boyd Peter E. | Sell | 2.29K | $0.96 | 2.20K |
| 2026-09-08 | Barber Daniel | Buy | 91.74K | $0.96 | 88.07K |
| 2026-09-08 | Barber Daniel | Sell | 91.74K | $0.96 | 88.07K |
| 2026-09-03 | Jung Cassie | Buy | 4.59K | $0.96 | 4.40K |
| 2026-09-03 | Jung Cassie | Sell | 4.59K | $0.96 | 4.40K |
| 2026-08-17 | Barber Daniel | Sell | 25.00K | $4.29 | 107.17K |
| 2026-08-14 | Korczynski Sherry | Sell | 2.71K | $4.25 | 11.53K |
| 2026-07-16 | Barber Daniel | Sell | 20.37K | $4.00 | 81.51K |
| 2026-07-15 | Barber Daniel | Sell | 4.63K | $4.03 | 18.68K |
| 2026-06-23 | Krop Julie | Buy | 25.00K | $0.71 | 17.83K |
| 2026-06-23 | Krop Julie | Sell | 25.00K | $5.02 | 125.39K |
| 2026-06-23 | Krop Julie | Sell | 25.00K | $0.71 | 17.83K |
| 2026-06-15 | Barber Daniel | Sell | 25.00K | $4.16 | 104.01K |
| 2026-06-10 | MORRIS TIMOTHY E | Buy | 50.50K | $3.99 | 201.50K |
| 2026-06-10 | Krop Julie | Buy | 50.50K | $3.99 | 201.50K |
| 2026-06-10 | Jenkins Abigail L. | Sell | 50.50K | $3.99 | 201.50K |
| 2026-06-10 | Cochran John | Buy | 50.50K | $3.99 | 201.50K |
| 2026-06-10 | BROWN GREGORY B | Buy | 50.50K | $3.99 | 201.50K |
| 2026-06-10 | Taglietti Marco | Buy | 50.50K | $3.99 | 201.50K |
| 2026-06-08 | Korczynski Sherry | Sell | 2.71K | — | — |
| 2026-05-18 | Zalewski Thomas A. | Buy | 100.00K | — | — |
| 2026-05-18 | Zalewski Thomas A. | Buy | 75.00K | $4.13 | 310.12K |
| 2026-05-15 | Barber Daniel | Sell | 8.26K | $4.29 | 35.41K |
| 2026-05-15 | Cioffi Melina | Sell | 1.67K | $4.17 | 6.95K |
| 2026-05-07 | BRAENDER LORI J | Sell | 135.69K | $4.23 | 573.97K |
| 2026-05-05 | Boyd Peter E. | Sell | 56.78K | $4.18 | 237.33K |
| 2026-05-05 | Barber Daniel | Sell | 335.92K | $4.18 | 1.40M |
| 2026-05-05 | TOTH A ERNEST JR | Sell | 92.65K | $4.18 | 387.29K |
| 2026-05-05 | Jung Cassie | Sell | 72.73K | $4.18 | 304.03K |
| 2026-05-05 | BRAENDER LORI J | Sell | 76.15K | $4.18 | 318.29K |
| 2026-04-02 | Zalewski Thomas A. | Other | 0 | — | — |
| 2026-03-10 | Boyd Peter E. | Sell | 29.81K | $4.17 | 124.41K |
| 2026-03-10 | Barber Daniel | Sell | 180.68K | $4.17 | 753.97K |
| 2026-03-10 | BRAENDER LORI J | Sell | 40.10K | $4.17 | 167.35K |
| 2026-03-10 | Cioffi Melina | Sell | 25.31K | $4.17 | 105.62K |
| 2026-03-10 | TOTH A ERNEST JR | Sell | 58.25K | $4.17 | 243.09K |
| 2026-03-10 | Korczynski Sherry | Sell | 15.74K | $4.17 | 65.69K |
| 2026-03-10 | Jung Cassie | Sell | 45.79K | $4.17 | 191.09K |
| 2026-03-09 | Boyd Peter E. | Buy | 80.00K | — | — |
| 2026-03-09 | Boyd Peter E. | Buy | 42.50K | $4.29 | 182.32K |
| 2026-03-09 | Barber Daniel | Buy | 262.00K | — | — |
| 2026-03-09 | Barber Daniel | Buy | 523.00K | $4.29 | 2.24M |
| 2026-03-09 | BRAENDER LORI J | Buy | 80.00K | — | — |
| 2026-03-09 | BRAENDER LORI J | Buy | 50.00K | $4.29 | 214.50K |
| 2026-03-09 | Cioffi Melina | Buy | 100.00K | — | — |
| 2026-03-09 | Cioffi Melina | Buy | 75.00K | $4.29 | 321.75K |
| 2026-03-09 | TOTH A ERNEST JR | Buy | 95.00K | — | — |
| 2026-03-09 | TOTH A ERNEST JR | Buy | 70.00K | $4.29 | 300.30K |
| 2026-03-09 | Korczynski Sherry | Buy | 75.00K | — | — |
| 2026-03-09 | Korczynski Sherry | Buy | 42.50K | $4.29 | 182.32K |
| 2026-03-09 | Jung Cassie | Buy | 80.00K | — | — |
| 2026-03-09 | Jung Cassie | Buy | 42.50K | $4.29 | 182.32K |
| 2026-03-09 | Davis Matthew W. | Buy | 50.00K | — | — |
| 2026-03-09 | Davis Matthew W. | Buy | 50.00K | $4.29 | 214.50K |
| 2026-03-09 | Greenhawt Matthew J. | Buy | 75.00K | — | — |
| 2026-03-09 | Greenhawt Matthew J. | Buy | 50.00K | $4.29 | 214.50K |
| 2026-03-02 | Greenhawt Matthew J. | Other | 0 | — | — |
| 2025-12-04 | Boyd Peter E. | Buy | 20.00K | — | — |
| 2025-12-02 | Cioffi Melina | Sell | 2.08K | $5.93 | 12.35K |
| 2025-11-10 | Davis Matthew W. | Buy | 50.00K | $5.58 | 279.00K |
| 2025-11-10 | Davis Matthew W. | Buy | 50.00K | — | — |
| 2025-11-03 | Davis Matthew W. | Other | 0 | — | — |
| 2025-10-15 | Jung Cassie | Buy | 25.00K | $3.10 | 77.57K |
| 2025-10-15 | Jung Cassie | Sell | 67.58K | $7.01 | 473.70K |
| 2025-10-15 | Jung Cassie | Sell | 25.00K | $3.10 | 77.57K |
| 2025-10-15 | Kraus Carl N | Sell | 20.27K | $7.00 | 141.90K |
| 2025-10-15 | Boyd Peter E. | Sell | 10.00K | $7.00 | 70.00K |
| 2025-09-26 | Barber Daniel | Sell | 91.34K | $6.03 | 551.19K |
| 2025-09-26 | Boyd Peter E. | Sell | 10.00K | $6.30 | 63.00K |
| 2025-09-19 | Barber Daniel | Sell | 400 | $6.00 | 2.40K |
| 2025-09-05 | Boyd Peter E. | Sell | 15.00K | $5.30 | 79.50K |
| 2025-09-04 | Jung Cassie | Buy | 25.00K | $0.71 | 17.66K |
| 2025-09-04 | Jung Cassie | Buy | 25.00K | $3.15 | 78.75K |
| 2025-09-04 | Jung Cassie | Sell | 62.18K | $5.00 | 310.90K |
| 2025-09-04 | Jung Cassie | Sell | 25.00K | $0.71 | 17.66K |
| 2025-09-04 | Jung Cassie | Sell | 25.00K | $3.15 | 78.75K |
| 2025-08-14 | Korczynski Sherry | Buy | 25.00K | — | — |
| 2025-08-09 | Kraus Carl N | Sell | 10.82K | $3.90 | 42.19K |
| 2025-06-11 | BROWN GREGORY B | Buy | 42.00K | $3.41 | 143.22K |
| 2025-06-11 | Krop Julie | Buy | 42.00K | $3.41 | 143.22K |
| 2025-06-11 | MORRIS TIMOTHY E | Buy | 42.00K | $3.41 | 143.22K |
| 2025-06-11 | Jenkins Abigail L. | Sell | 42.00K | $3.41 | 143.22K |
| 2025-06-11 | Cochran John | Buy | 42.00K | $3.41 | 143.22K |
| 2025-06-11 | Taglietti Marco | Buy | 42.00K | $3.41 | 143.22K |
| 2025-06-09 | Korczynski Sherry | Sell | 2.71K | $3.54 | 9.61K |
| 2025-05-15 | Cioffi Melina | Buy | 20.00K | — | — |
| 2025-04-25 | Cioffi Melina | Other | 0 | — | — |
| 2025-03-10 | Wargacki Stephen | Sell | 4.57K | $2.54 | 11.61K |
| 2025-03-10 | Jung Cassie | Sell | 2.18K | $2.54 | 5.54K |
| 2025-03-09 | Wargacki Stephen | Sell | 15.43K | $2.65 | 40.89K |
| 2025-03-09 | Jung Cassie | Sell | 8.00K | $2.65 | 21.19K |
| 2025-03-09 | TOTH A ERNEST JR | Sell | 8.74K | $2.65 | 23.15K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 195, holders +8 vs prior quarter. Ownership 57.86%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BRATTON CAPITAL MANAGEMENT, L.P. | 9.81M | 0 | 0.00% | 40.81M |
| BLACKROCK, INC. | 8.07M | 560.30K | +7.46% | 33.57M |
| RTW INVESTMENTS, LP | 7.43M | 0 | 0.00% | 30.89M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.58M | 140.84K | +3.17% | 19.07M |
| FEDERATED HERMES, INC. | 3.11M | 172.22K | +5.86% | 12.95M |
| STATE STREET CORP | 2.93M | 381.83K | +15.00% | 12.18M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.62M | 214.70K | +8.92% | 10.91M |
| SAMSARA BIOCAPITAL, LLC | 2.50M | 0 | 0.00% | 10.40M |
| BANK OF AMERICA CORP /DE/ | 1.67M | -736.63K | -30.63% | 6.94M |
| SIO CAPITAL MANAGEMENT, LLC | 1.49M | -436.71K | -22.71% | 6.18M |
| PROPEL BIO MANAGEMENT, LLC | 1.44M | 731.41K | +102.87% | 6.00M |
| WASATCH ADVISORS LP | 1.39M | 507.53K | +57.78% | 5.77M |
| TWO SIGMA INVESTMENTS, LP | 1.28M | 141.82K | +12.45% | 5.33M |
| NUVEEN, LLC | 1.22M | 961.76K | +379.44% | 5.06M |
| JANNEY MONTGOMERY SCOTT LLC | 1.11M | 17.05K | +1.57% | 4.60M |
| WELLS FARGO & COMPANY/MN | 1.09M | 54.39K | +5.26% | 4.53M |
| COMMONWEALTH EQUITY SERVICES, LLC | 1.05M | -36.51K | -3.37% | 4.35M |
| BARCLAYS PLC | 996.66K | 197.50K | +24.71% | 4.15M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 949.80K | 628.50K | +195.61% | 3.95M |
| BLUE OWL CAPITAL HOLDINGS LP | 942.93K | -405.00K | -30.05% | 3.92M |
| NORTHERN TRUST CORP | 831.15K | 98.65K | +13.47% | 3.46M |
| BNP PARIBAS FINANCIAL MARKETS | 794.69K | -14.32K | -1.77% | 3.31M |
| BALYASNY ASSET MANAGEMENT L.P. | 744.54K | -2.16M | -74.33% | 3.10M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 734.25K | 42.49K | +6.14% | 3.05M |
| MORGAN STANLEY | 658.62K | -933.17K | -58.62% | 2.74M |
Earnings and financials
Aquestive Therapeutics, Inc. (AQST) trades at $4.16, with a market cap of $521.50M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn